Foclivia Sospensione iniettabile in una siringa Preriempita

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

Available from:

Medius AG

ATC code:

J07BB02

INN (International Name):

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

Pharmaceutical form:

Sospensione iniettabile in una siringa Preriempita

Composition:

haemagglutininum influenzae A (H5N1) et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14) 7.5 µg, adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.

Class:

B

Therapeutic group:

Vaccini

Therapeutic area:

Pandemico Influenzale Vaccino

Authorization status:

zugelassen

Authorization date:

2018-04-20